2007-05-30
InferMed appoints new CEO
InferMed, a leading provider of advanced software solutions for clinical research and practice, has appointed Duane S. Lawrence as its Chief Executive Officer.
Mr Lawrence joins InferMed from MISYS Healthcare Systems International, where he held the role of General Manager from 2003. In this role he was responsible for all aspects of Misys Healthcare operations outside North America, researching and opening new international markets across Europe as well as the Middle East and Asia.
Commenting on his appointment, Mr Lawrence said: “I am very pleased to be joining the InferMed team at this important time in their development. The company is uniquely positioned for dramatic growth in the healthcare and pharma space as our MACRO and Arezzo® solutions are significantly ahead of other competitive products. We are clearly positioned today to make important advances for our global client base, supporting clinical research and physicians in improving patient care.”
Before becoming General Manager at MISYS, Duane initiated, developed and grew the Product Management and Account Management functions at Misys Healthcare as well as holding the positions of Director, Client Implementation Services and Regional Sales Manager. Prior to this Duane held top sales roles in the US with B Braun Medical and Coca Cola USA, following his graduation from Notre Dame University with a B.B.A in Finance.
Roger Wallhouse, Chairman of InferMed, said: “This appointment marks a significant step in the development of InferMed. With his excellent track record in sales, and a proven ability to develop new markets, Duane will be hugely important in driving forward InferMed’s sales of MACRO and Arezzo, and ensuring InferMed extends its position as a leading software provider.”
